In prostate cancer, downregulation of LARGE2, a paralog of LARGE, resulted in hypoglycosylation of α-dystroglycan and loss of its ability to bind laminin 111, thus promoting cellular phenotypes associated with cancer progression and metastasis [25]. This evidence concerns the gene DAG1 and cancer.